trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,lung02', 'lung', 'astrazeneca', 'daiichi']
attending #esmo22? join us tomorrow as we present results from the destiny-lung02 phase ii trial in her2-mutant metastatic non-small cell #lungcancer with our collaborators 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.